BackMaravai LifeSciences Holdings Overview
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A

Maravai LifeSciences Holdings Target Price

Analysts' average 12-month price target for Maravai LifeSciences Holdings is $6.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.74

Average Target Price

$6.004.5% upside

1 analysts in the last 4 months

High: $6 | Low: $6

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-08Deutsche Bank$64.5% upsideOpen
2025-12-15Wells FargoBrandon Couillard$4.521.6% downsideOpen
2025-03-21Stifel Nicolaus$512.9% downsideOpen
2024-05-09Robert W. BairdCatherine Schulte$1074.2% upsideOpen
2022-12-14Deutsche Bank$25335.5% upsideOpen
2022-12-07RBC Capital$22283.3% upsideOpen

Maravai LifeSciences Holdings (MRVI) FAQ

As of the most recent data, MRVI shows a target price of $6. Scroll down for historical charts and peer comparison views.

If Maravai LifeSciences Holdings moved to the average analyst target of $6, shares would be roughly 4.5% higher than $5.74. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Maravai LifeSciences Holdings's earnings trajectory.

Besides this target price page, Stockcircle has Maravai LifeSciences Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $6) with ownership activity and broader fundamentals.

Maravai LifeSciences Holdings's target price is $6; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.